1 Result

People

  1. Arcila
    Arcila
  2. Bowman
    Bowman
  3. Brogi
    Brogi
  4. Hoda
    Hoda
  5. Ladanyi
    Ladanyi
  6. Razavi
    Razavi
  7. Ross
    Ross
  8. Wen
    Wen
  9. Zehir
    Zehir

Groups

  1. Breast Medicine Service (1)
  2. Department of Medicine (1)
  3. Department of Pathology and Laboratory Medicine (1)
  4. GSK Faculty (1)
  5. Human Oncology and Pathogenesis Program (1)
  6. Solid Tumor Oncology Division (1)
  7. Tow Center for Developmental Oncology (TCDO) (1)
  8. Weinberg Fellows (1)
  1. "asco/cap guideline"
Formats
  1. Journal Article (1)
Groups
  1. Breast Medicine Service (1)
  2. Department of Medicine (1)
  3. Department of Pathology and Laboratory Medicine (1)
  4. GSK Faculty (1)
  5. Human Oncology and Pathogenesis Program (1)
  6. Solid Tumor Oncology Division (1)

More Groups

People
  1. Ahmet Zehir (1)
  2. Anita Bowman (1)
  3. Dara Ross (1)
  4. Edi Brogi (1)
  5. Hannah Wen (1)
  6. Marc Ladanyi (1)

More People

Years
  1. 2021 (1)
Publications
  1. Histopathology (1)
Publishers
  1. Wiley Blackwell (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: A focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline
    Journal Article

    Hoda, R. S.; Bowman, A. S.; Zehir, A.; Razavi, P.; Brogi, E.; Ladanyi, M.; Arcila, M. E.; Wen, H. Y.; Ross, D. S.
    Histopathology (2021)

    Fulltext@MSK | Save